Dr Sean Brian Harris, PSYD | |
18350 Mount Langley St Ste 220, Fountain Valley, CA 92708-6912 | |
(714) 378-2620 | |
Not Available |
Full Name | Dr Sean Brian Harris |
---|---|
Gender | Male |
Speciality | Psychologist - Clinical Child & Adolescent |
Location | 18350 Mount Langley St Ste 220, Fountain Valley, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346616554 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC2200X | Psychologist - Clinical Child & Adolescent | PSY34875 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sean Brian Harris, PSYD 130 S B St, Tustin, CA 92780-3609 Ph: (888) 265-9114 | Dr Sean Brian Harris, PSYD 18350 Mount Langley St Ste 220, Fountain Valley, CA 92708-6912 Ph: (714) 378-2620 |
News Archive
An RTP-based pharmaceutical company with roots at the University of North Carolina at Chapel Hill has received $33 million in Series B venture capital funding to develop more effective and less toxic methods to treat patients with cancer.
Nearly three quarters of women's rights advocates say ending violence against women must be a top priority for U.N. Women, according to a report released Wednesday at the Commission on the Status of Women in New York, Inter Press Service reports.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
It's a sound that saves. A "real-time" radiation monitor that alerts by beeping in response to radiation exposure during cardiac-catheterization procedures significantly reduces the amount of exposure that medical workers receive, UT Southwestern Medical Center researchers found.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
› Verified 7 days ago
Huma Athar-macdonald, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 18627 Brookhurst St, Ste 520, Fountain Valley, CA 92708 Phone: 310-991-6133 | |
Dr. Stanley Jay Silverstein, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10101 Slater Ave, Suite 237, Fountain Valley, CA 92708 Phone: 714-293-4857 | |
Norrette T Lohr-thierry, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 10061 Talbert Ave, 200, Fountain Valley, CA 92708 Phone: 714-878-4616 | |
Maurie Edelman, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10101 Slater Ave, Suite 241, Fountain Valley, CA 92708 Phone: 714-378-2620 Fax: 714-378-2631 | |
Ana Carina D'abreu, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 18350 Mount Langley St Ste 200, Fountain Valley, CA 92708 Phone: 714-378-2620 Fax: 714-378-2631 | |
Jacquelyn Harlan, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9550 Warner Ave Ste 250, Fountain Valley, CA 92708 Phone: 714-593-2300 | |
Mrs. Carolyn Hunter, LEP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10055 Slater Avenue, Fountain Valley, CA 92708 Phone: 714-843-3200 Fax: 714-843-3230 |